Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

9.110 +0.140 (+1.56%)

Streaming Delayed Price Updated: 10:52 AM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

5 Top Stocks Cathie Wood Is Buying This Week ↗

October 07, 2022

Ark Invest is making headlines again. Cathie Wood continues to purchase more shares of companies like Tesla despite headwinds.

Via InvestorPlace

2 Growth Stocks That Could Rocket 80% to 102% Higher, According to Wall Street ↗

October 07, 2022

Analysts expect these stocks to rise more than 100% once the rest of the market sees their underlying businesses in the same light.

Via The Motley Fool

Co-founders Keep Buying Ginkgo Bioworks (DNA) Stock ↗

October 06, 2022

Three co-founders of Ginkgo Bioworks, including CEO Jason Kelly, have filed updated forms detailing their increased stakes in DNA stock.

Via InvestorPlace

Analyzing Ginkgo Bioworks Holdings's Short Interest ↗

October 06, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 8.12% since its last report. The company recently reported that it has 187.61 million shares sold short, which is 25.02% of all...

Via Benzinga

Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock ↗

October 06, 2022

The famed investor who focuses on disruptive technologies has been buying DNA stock hand-over-fist in recent days.

Via InvestorPlace

Why Is Ginkgo Bioworks Stock Up Today? ↗

October 04, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company announced the acquisitions of Altar and Circularis. Terms of the deals were not disclosed.

Via Benzinga

Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition ↗

August 19, 2022

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

September 30, 2022

There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public.

Via InvestorPlace

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

Cramer Warns Investor To Avoid This Entire Industry: 'I Do Not Want You To Touch Any Of These Stocks' ↗

September 28, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money.

Via Benzinga

Peering Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

September 20, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 24.11% since its last report. The company recently reported that it has 179.06 million shares sold short...

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

September 09, 2022

Cathie Wood's Ark Invest had an active week of buying shares in companies like DKNG and TDOC. Investors are intrigued by Cathie Wood stocks.

Via InvestorPlace

Don’t Jump Into the Deepening Financial Hole with Ginkgo Bioworks ↗

August 29, 2022

You don't have to mimic Wood's trades, as DNA stock could continue its downward trajectory due to Ginkgo Bioworks' imperfect financials.

Via InvestorPlace

5 Cathie Wood Stocks Signaling “The Bear Market Is Over” ↗

August 22, 2022

These top Cathie Wood stocks are signalling that the bear market is over. For savvy investors, that presents a chance to profit.

Via InvestorPlace

Wayfair, Bed Bath & Beyond And Other Big Losers From Friday ↗

August 22, 2022

U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Cathie Wood Is Doubling Down on Ginkgo Bioworks (DNA) Stock ↗

August 19, 2022

Notorious ARK Fund Manager Cathie Wood has continued her investment into Ginkgo Bioworks this week. Despite this, DNA stock is down today.

Via InvestorPlace

Walmart, Gap, Nordstrom And Some Other Big Stocks Recording Gains On Tuesday ↗

August 17, 2022

U.S. stocks closed mostly higher on Tuesday, with the Dow Jones gaining around 240 points. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗

August 17, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Via Benzinga

Why Is FuboTV (FUBO) Stock Up 55% Today? ↗

August 16, 2022

FuboTV (FUBO) stock is rising higher on Tuesday after the company announced an update to its leadership team.

Via InvestorPlace

What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗

August 16, 2022

Ginkgo Bioworks is trending today after crushing its Q2 earnings call this morning. DNA stock is up more than 10% on strong revenue growth.

Via InvestorPlace

Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session ↗

August 16, 2022

Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.

Via Benzinga

Raymond James Maintains Outperform Rating for Ginkgo Bioworks Holdings: Here's What You Need To Know ↗

August 16, 2022

Raymond James has decided to maintain its Outperform rating of Ginkgo Bioworks Holdings (NYSE:DNA) and raise its price target from $11.50 to $14.50. Shares of Ginkgo Bioworks Holdings are trading up...

Via Benzinga

Why Ginkgo Bioworks Stock Is Soaring Today ↗

August 16, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company reported strong financial results and raised full-year guidance above analyst estimates.

Via Benzinga

Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 16, 2022

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 16, 2022

It's time for an overview of the biggest pre-market stock movers for Tuesday and the news that's affecting them this morning.

Via InvestorPlace

Why IZEA Worldwide Shares Are Trading Higher By Over 30%: Here Are 37 Stocks Moving Premarket ↗

August 16, 2022

Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million,...

Via Benzinga

Why Cathie Wood Favorite Ginkgo Bioworks Is Surging After Hours ↗

August 15, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher in Monday's after-hours session after the company reported strong financial results and raised full-year guidance above analy

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.